Heat-Related Illness Increasing in the United States
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 28, 2023 -- There has been a statistically significant increase in the incidence of heat-related illnesses during the last several decades in the United States, according to a study published online July 7 in the Journal of Climate Change and Health.
Thomas F. Osborne, M.D., from the U.S. Department of Veterans Affairs (VA) Palo Alto Healthcare System in California, and colleagues used VA electronic health data (2002 through 2019) to examine associations between patient demographics and comorbidities with heat-related illness.
The researchers identified 33,114 cases of heat-related illness among 28,039 unique patients during the 18-year period. Over time, there was a significant increase in the rate of heat-related illness, which was diagnosed in all 50 states. Higher comorbidity burden was associated with a greater likelihood of heat-related illnesses. Homeless veterans had increased rates of heat-related illness in the first half of the assessment period and declining rates in the second half. A greater proportion of heat-related illnesses occurred among Black and American Indian/Alaska Native veterans.
"There has also been an increased number of heat-related diagnoses associated with existing health and demographic factors, and the increase over time did not strictly follow the expected geographic North-South climate trends," conclude the authors.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.